EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD introduces BioFX® TMB Enhanced HRP Membrane Substrate. SurModics IVD, a wholly owned subsidiary of SurModics, Inc. (Nasdaq: SRDX), is a market leader for immunoassay reagents for diagnostic test kits used to detect absence or presence of disease.
